Oxford Immune Algorithmics
Healthcare Software · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Richfield Ave, Reading, Berkshire, RG...Website
www.immunealgorithmics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Oxford Immune Algorithmics
Algocyte leverages artificial general intelligence (AGI) to transform healthcare from reactive to preventive by monitoring subtle blood changes over time. The company provides a user-friendly mobile health station that integrates with wearable devices and electronic health records, offering actionable insights for chronic disease management. Targeting patients, clinicians, and payors, Algocyte aims to reduce hospital visits and costs while empowering users with real-time health data. Incubated at Oxford and developed at Kings College London, Algocyte is setting a new standard in precision healthcare.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oxford Immune Algorithmics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Oxford Immune Algorithmics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Oxford Immune Algorithmics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Oxford Immune Algorithmics
Website visits: Recent activity has been detected on your website
Oxford Immune Algorithmics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Oxford Immune Algorithmics is spiking on competitors!
Earning: See what the market has to say on Oxford Immune Algorithmics recently announced quarterly report
Check if Oxford Immune Algorithmics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Oxford Immune Algorithmics launches new products
Recommended Actions
Reach out to Masked Content who joined Oxford Immune Algorithmics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Oxford Immune Algorithmics
Compare insights from companies similar to Oxford Immune Algorithmics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Oxford Immune Algorithmic...
<$5M
11-50
Private
-
2018
N/A
Company Profile Activity
Activity Insights
Oxford Immune Algorithmics is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Oxford Immune Algorithmics is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Oxford Immune Algorithmics.
Oxford Immune Algorithmics Tech Stack
A closer look at the technologies used by Oxford Immune Algorithmics
Most Recent Scoops
Project
A front-line source in Artificial Intelligence has indicated that the organization is in the midst of initiatives related to user interface (UI). Oxford Immune Algorithmics Ltd is currently evaluating vendors to support these efforts. The organization is focusing on mobile application development as part of these initiatives.
Application Development, Machine Learning, User Interface
Project
A front-line source in Artificial Intelligence has indicated that the organization is in the midst of initiatives related to web development. Oxford Immune Algorithmics Ltd is currently evaluating vendors to support these efforts. The organization is focusing on the user interface (UI) and user experience (UX) of web applications as part of these initiatives.
Collaboration/Web Apps, Application Development, User Experience, Website, Machine Learning, User Interface
Project
A front-line source in Artificial Intelligence has indicated that the organization is in the midst of initiatives related to data labeling. Oxford Immune Algorithmics Ltd is currently evaluating V7 Darwin. The organization has expressed interest in an artificial intelligence (AI) based tool for trend and data analysis.
Data Management, Machine Learning
Project
A front-line source in Artificial Intelligence has indicated that the organization is in the midst of initiatives related to quality assurance. Oxford Immune Algorithmics Ltd is currently evaluating vendors to support these efforts. The organization is working to deploy quality management system (QMS) protocols and strategies as part of these initiatives.
Implementation, Quality Assurance, Machine Learning, Quality Management
Project
Machine Learning
Oxford Immune Algorithmics News & Media
Where AI Meets Immunity: Oxford Immune Algorithmics to Launch Predictive Medicine Solution
UK-based Oxford Immune Algorithmics will launch Algocyte, an end-to-end predictive health solution that uses AI to quickly conduct blood diagnostic tests. The system is expected to come out this yearReading, Berkshire, March 03, 2023 (GLOBE NEWSWIRE) -- Oxford Immune Algorithmics (OIA) will launch its Algocyte end-to-end health solution harnessing artificial intelligence (AI) for its cloud-based predictive medicine platform. While AI text and image generators have been gaining notoriety amid fea
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oxford Immune Algorithmics
Sign Up For FreeTo access detailed company insights
Algocyte leverages artificial general intelligence (AGI) to transform healthcare from reactive to preventive by monitoring subtle blood changes over time. The company provides a user-friendly mobile health station that integrates with wearable devices and electronic health records, offering actionable insights for chronic disease management. Target... Read More
